Altamira Therapeutics Ltd.: xbrl:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables

Value{"unit": "CHF", "value": -62835}
Period2023-01-01 – 2023-06-30
Statussuperseded
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-23-075871
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/66d476ec-bc2d-4de7-a15b-6282bf9e8050

History